THE CURRENT STATE OF RESEARCH AND INSIGHT

A book intended for researchers, epidemiologists with interest in genetic disease

THE CURRENT STATE OF RESEARCH AND INSIGHT

Leigh Spielberg

Published: Friday, May 1, 2020

Advances in Vision Research, Volume II (Springer) covers "Genetic Eye Research in Asia and the Pacific". Edited by Gyan Prakesh and Takeshi Iwata, this text, part of the "Essentials in Ophthalmology" series, is a resource on the current state of research and insight into a historically under-investigated population that also happens to be the largest in the world. Examples of topics covered are "Stargardt Disease in Asian Populations", "Genomic Approaches to Eye Diseases: An Asian Perspective" and "Myopia Genes in Asians". This book is intended for researchers, epidemiologists with interest in genetic disease and ophthalmologists with a particular focus on genetic eye disease who also see a significant number of patients of Asian or Pacific origin.

Tags: research

Latest Articles

ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Supplement: ESCRS Clinical Trends Series: Presbyopia

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.